vs
Side-by-side financial comparison of Globalstar, Inc. (GSAT) and SBC Medical Group Holdings Inc (SBC). Click either name above to swap in a different company.
Globalstar, Inc. is the larger business by last-quarter revenue ($72.0M vs $39.6M, roughly 1.8× SBC Medical Group Holdings Inc). SBC Medical Group Holdings Inc runs the higher net margin — 35.9% vs -16.1%, a 52.0% gap on every dollar of revenue. On growth, Globalstar, Inc. posted the faster year-over-year revenue change (17.6% vs -10.9%). Over the past eight quarters, Globalstar, Inc.'s revenue compounded faster (12.9% CAGR vs -15.0%).
Globalstar, Inc. is an American telecommunications company that operates a satellite constellation in low Earth orbit (LEO) for satellite phone, low-speed data transmission and Earth observation. The Globalstar second-generation constellation consists of 25 satellites.
SBC Medical Group Holdings Inc. is a leading Japan-headquartered healthcare provider primarily focused on aesthetic medicine, dermatology, and anti-aging wellness services. It operates an extensive network of clinics across Japan, catering to both domestic patients and international medical tourists, with core offerings including cosmetic surgery and non-invasive skincare treatments.
GSAT vs SBC — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $72.0M | $39.6M |
| Net Profit | $-11.6M | $14.2M |
| Gross Margin | — | 73.1% |
| Operating Margin | -0.5% | 32.5% |
| Net Margin | -16.1% | 35.9% |
| Revenue YoY | 17.6% | -10.9% |
| Net Profit YoY | 76.9% | 117.2% |
| EPS (diluted) | $-0.11 | $0.15 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $72.0M | $39.6M | ||
| Q3 25 | $73.8M | $43.4M | ||
| Q2 25 | $67.1M | $43.4M | ||
| Q1 25 | $60.0M | $47.3M | ||
| Q4 24 | $61.2M | $44.4M | ||
| Q3 24 | $72.3M | $53.1M | ||
| Q2 24 | $60.4M | $53.1M | ||
| Q1 24 | $56.5M | $54.8M |
| Q4 25 | $-11.6M | $14.2M | ||
| Q3 25 | $1.1M | $12.8M | ||
| Q2 25 | $19.2M | $2.5M | ||
| Q1 25 | $-17.3M | $21.5M | ||
| Q4 24 | $-50.2M | $6.5M | ||
| Q3 24 | $9.9M | $2.8M | ||
| Q2 24 | $-9.7M | $18.5M | ||
| Q1 24 | $-13.2M | $18.8M |
| Q4 25 | — | 73.1% | ||
| Q3 25 | — | 70.6% | ||
| Q2 25 | — | 69.2% | ||
| Q1 25 | — | 79.7% | ||
| Q4 24 | — | 76.3% | ||
| Q3 24 | — | 81.5% | ||
| Q2 24 | — | 74.2% | ||
| Q1 24 | — | 72.1% |
| Q4 25 | -0.5% | 32.5% | ||
| Q3 25 | 13.8% | 36.6% | ||
| Q2 25 | 9.2% | 33.6% | ||
| Q1 25 | -14.2% | 51.1% | ||
| Q4 24 | -6.9% | 10.6% | ||
| Q3 24 | 13.0% | 26.1% | ||
| Q2 24 | -2.4% | 51.4% | ||
| Q1 24 | -8.3% | 44.6% |
| Q4 25 | -16.1% | 35.9% | ||
| Q3 25 | 1.5% | 29.6% | ||
| Q2 25 | 28.6% | 5.7% | ||
| Q1 25 | -28.9% | 45.4% | ||
| Q4 24 | -82.1% | 14.7% | ||
| Q3 24 | 13.7% | 5.3% | ||
| Q2 24 | -16.0% | 34.8% | ||
| Q1 24 | -23.4% | 34.2% |
| Q4 25 | $-0.11 | $0.15 | ||
| Q3 25 | $-0.01 | $0.12 | ||
| Q2 25 | $0.13 | $0.02 | ||
| Q1 25 | $-0.16 | $0.21 | ||
| Q4 24 | $-0.57 | $0.05 | ||
| Q3 24 | $0.00 | $0.03 | ||
| Q2 24 | $-0.01 | $0.20 | ||
| Q1 24 | $-0.01 | $0.20 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $447.5M | $164.1M |
| Total DebtLower is stronger | $483.8M | $42.8M |
| Stockholders' EquityBook value | $355.7M | $248.3M |
| Total Assets | $2.3B | $380.4M |
| Debt / EquityLower = less leverage | 1.36× | 0.17× |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $447.5M | $164.1M | ||
| Q3 25 | $346.3M | $127.4M | ||
| Q2 25 | $308.2M | $152.7M | ||
| Q1 25 | $241.4M | $132.1M | ||
| Q4 24 | $391.2M | $125.0M | ||
| Q3 24 | $51.9M | $137.4M | ||
| Q2 24 | $64.3M | — | ||
| Q1 24 | $59.3M | — |
| Q4 25 | $483.8M | $42.8M | ||
| Q3 25 | $508.6M | $21.1M | ||
| Q2 25 | $491.5M | $7.1M | ||
| Q1 25 | $502.7M | $6.9M | ||
| Q4 24 | $511.4M | $6.6M | ||
| Q3 24 | $394.4M | $823.2K | ||
| Q2 24 | $393.1M | — | ||
| Q1 24 | $398.7M | — |
| Q4 25 | $355.7M | $248.3M | ||
| Q3 25 | $364.8M | $248.0M | ||
| Q2 25 | $360.9M | $244.6M | ||
| Q1 25 | $344.3M | $226.4M | ||
| Q4 24 | $358.9M | $195.1M | ||
| Q3 24 | $394.1M | $205.0M | ||
| Q2 24 | $383.0M | $8.8M | ||
| Q1 24 | $377.1M | $9.0M |
| Q4 25 | $2.3B | $380.4M | ||
| Q3 25 | $2.2B | $321.4M | ||
| Q2 25 | $1.9B | $315.3M | ||
| Q1 25 | $1.7B | $284.6M | ||
| Q4 24 | $1.7B | $266.1M | ||
| Q3 24 | $917.6M | $296.5M | ||
| Q2 24 | $926.2M | $19.5M | ||
| Q1 24 | $917.0M | $19.8M |
| Q4 25 | 1.36× | 0.17× | ||
| Q3 25 | 1.39× | 0.09× | ||
| Q2 25 | 1.36× | 0.03× | ||
| Q1 25 | 1.46× | 0.03× | ||
| Q4 24 | 1.43× | 0.03× | ||
| Q3 24 | 1.00× | 0.00× | ||
| Q2 24 | 1.03× | — | ||
| Q1 24 | 1.06× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $175.9M | $52.0M |
| Free Cash FlowOCF − Capex | — | $51.2M |
| FCF MarginFCF / Revenue | — | 129.3% |
| Capex IntensityCapex / Revenue | — | 2.0% |
| Cash ConversionOCF / Net Profit | — | 3.66× |
| TTM Free Cash FlowTrailing 4 quarters | — | $23.3M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $175.9M | $52.0M | ||
| Q3 25 | $236.0M | $-20.9M | ||
| Q2 25 | $157.9M | $-8.3M | ||
| Q1 25 | $51.9M | $1.9M | ||
| Q4 24 | $340.7M | $-7.3M | ||
| Q3 24 | $32.0M | $5.0M | ||
| Q2 24 | $36.7M | $19.2M | ||
| Q1 24 | $29.8M | $3.7M |
| Q4 25 | — | $51.2M | ||
| Q3 25 | — | $-20.9M | ||
| Q2 25 | — | $-8.6M | ||
| Q1 25 | — | $1.7M | ||
| Q4 24 | — | $-7.9M | ||
| Q3 24 | — | $4.6M | ||
| Q2 24 | — | $18.3M | ||
| Q1 24 | — | $3.0M |
| Q4 25 | — | 129.3% | ||
| Q3 25 | — | -48.3% | ||
| Q2 25 | — | -19.9% | ||
| Q1 25 | — | 3.5% | ||
| Q4 24 | — | -17.8% | ||
| Q3 24 | — | 8.7% | ||
| Q2 24 | — | 34.5% | ||
| Q1 24 | — | 5.4% |
| Q4 25 | — | 2.0% | ||
| Q3 25 | — | 0.1% | ||
| Q2 25 | — | 0.7% | ||
| Q1 25 | — | 0.5% | ||
| Q4 24 | — | 1.3% | ||
| Q3 24 | — | 0.8% | ||
| Q2 24 | — | 1.6% | ||
| Q1 24 | — | 1.3% |
| Q4 25 | — | 3.66× | ||
| Q3 25 | 216.53× | -1.63× | ||
| Q2 25 | 8.22× | -3.39× | ||
| Q1 25 | — | 0.09× | ||
| Q4 24 | — | -1.12× | ||
| Q3 24 | 3.23× | 1.77× | ||
| Q2 24 | — | 1.04× | ||
| Q1 24 | — | 0.20× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GSAT
| Services | $67.4M | 94% |
| Products | $4.6M | 6% |
SBC
| Franchising | $10.3M | 26% |
| Medical Corporation Shobikai | $8.1M | 21% |
| Medical Corporation Nasukai | $7.2M | 18% |
| Management Services | $6.3M | 16% |
| Rental Services | $4.3M | 11% |
| Medical Corporation Association Furinkai | $3.0M | 8% |
| Japan Medical And Beauty Inc | $656.5K | 2% |
